These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 33975553

  • 1. Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders.
    Xia M, Zheng J.
    BMC Pregnancy Childbirth; 2021 May 11; 21(1):372. PubMed ID: 33975553
    [Abstract] [Full Text] [Related]

  • 2. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B, Geerts D, Hu S, Yue J, Li Z, Zhu G, Jin L.
    Hum Reprod; 2020 Jun 01; 35(6):1306-1318. PubMed ID: 32478400
    [Abstract] [Full Text] [Related]

  • 3. A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial.
    Xu B, Geerts D, Yuan J, Wang M, Li Z, Lai Q, Zheng Y, Liu S, Yang S, Zhu G, Jin L.
    Hum Reprod; 2024 Sep 01; 39(9):1969-1978. PubMed ID: 38942602
    [Abstract] [Full Text] [Related]

  • 4. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 01; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD008046. PubMed ID: 25358904
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 31; 47(4):245-9. PubMed ID: 22781108
    [Abstract] [Full Text] [Related]

  • 7. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX, Zhang T, Shu L, Huang J, Diao FY, Ding W, Gao Y, Wang W, Mao YD, Cui YG, Liu JY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar 25; 53(3):160-166. PubMed ID: 29609229
    [Abstract] [Full Text] [Related]

  • 8. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A.
    Hum Reprod; 2017 Mar 01; 32(3):556-567. PubMed ID: 28130435
    [Abstract] [Full Text] [Related]

  • 9. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H, Aboulghar M.
    Cochrane Database Syst Rev; 2001 Mar 01; (4):CD001750. PubMed ID: 11687120
    [Abstract] [Full Text] [Related]

  • 10. [Gonadotropin-releasing hormone antagonist protocol in patients with risk of poor response to ovarian stimulation in IVF-ET].
    Sun Y, Zhu YM.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 May 01; 38(3):305-10. PubMed ID: 19504641
    [Abstract] [Full Text] [Related]

  • 11. Frozen-thawed cleavage-stage embryo transfer cycles after previous GnRH agonist or antagonist stimulation.
    Bahçeci M, Ulug U, Erden HF, Tosun S, Ciray N.
    Reprod Biomed Online; 2009 Jan 01; 18(1):67-72. PubMed ID: 19146771
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD008046. PubMed ID: 21249699
    [Abstract] [Full Text] [Related]

  • 13. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD008046. PubMed ID: 21069701
    [Abstract] [Full Text] [Related]

  • 14. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
    Kdous M, Chaker A, Bouyahia M, Zhioua F, Zhioua A.
    Tunis Med; 2009 Dec 10; 87(12):834-42. PubMed ID: 20209851
    [Abstract] [Full Text] [Related]

  • 15. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation.
    Geng Y, Xun Y, Hu S, Lai Q, Jin L.
    Gynecol Endocrinol; 2019 Apr 10; 35(4):309-313. PubMed ID: 30430883
    [Abstract] [Full Text] [Related]

  • 16. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC, Engin Ustun Y.
    J Obstet Gynaecol; 2020 Aug 10; 40(6):837-842. PubMed ID: 31791167
    [Abstract] [Full Text] [Related]

  • 17. [Comparative Study of the Embryo Development and Clinical Outcomes of 3 Ovarian Stimulation Protocols in Different Age Groups].
    Fan Y, Zhang W, Zhang Z.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May 20; 55(3):580-587. PubMed ID: 38948300
    [Abstract] [Full Text] [Related]

  • 18. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
    Wei LH, Ma WH, Tang N, Wei JH.
    Taiwan J Obstet Gynecol; 2016 Feb 20; 55(1):50-4. PubMed ID: 26927248
    [Abstract] [Full Text] [Related]

  • 19. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN, Peng JL, Yang J, Xu WM.
    Curr Med Sci; 2019 Jun 20; 39(3):431-436. PubMed ID: 31209815
    [Abstract] [Full Text] [Related]

  • 20. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X, Yang J, Li L, Yang N, Lan L, Huang G, Ye H.
    BMC Pregnancy Childbirth; 2021 Mar 12; 21(1):207. PubMed ID: 33711956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.